Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel series of reversible USP7 inhibitors as oncolytic drugs presented

April 3, 2019

Fish slime helps turn the tide against antibiotic resistance

April 3, 2019

New Alzheimer's disease model differentiates the role of C99 from beta-amyloid

April 3, 2019

Tesamorelin leads to significant reductions in liver fat in HIV patients with NAFLD

April 3, 2019

Sangamo and Pfizer announce phase I/II interim data for SB-525 gene therapy

April 3, 2019

FDA approves IND application for Incysus' gamma-delta T-cell therapy

April 3, 2019

Patient enrollment underway in phase I study of AGEN-1181

April 3, 2019

Prenatal treatment improves cystic fibrosis

April 3, 2019

Drug takes aim at TB enzyme and its backup

April 3, 2019

Re-turning turncoat macrophages

April 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...